Sunday, September 6, 2026

Celltrion’s Three ADC Drug Candidates All Receive FDA Fast Track Designation

Celltrion has secured U.S. FDA Fast Track designation for all three of its antibody-drug conjugate candidates, accelerating development of its emerging oncology drug pipeline.

Kim Jong Un Awards Troops for Russia Missions, Builds Wall of Remembrance

Kim Jong Un honors soldiers from overseas operations, awarding titles and medals, while expressing condolences to bereaved families.

Counterfeit Chaos: 50,000 Fake Products Seized from China

South Korean Customs has uncovered over 50,000 counterfeit products illegally entering the country through Chinese e-commerce platforms.

Tag: anti-cancer effects

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.